The global interleukin-6 (IL-6) inhibitors market is set for remarkable growth, with its value expected to rise from USD 33.3 billion in 2023 to USD 93.3 billion by 2033. This anticipated expansion represents a compound annual growth rate (CAGR) of 10.9% over the forecast period, according to recent research by Future Market Insights. At the …